# Novel Resolvin D1-Loaded Biologics as an Advanced Approach for Inflammation Control and Tissue Regeneration: Preparation and Characterization

**Authors:** Zhe Xing, Jingwen Liang, Yang Sun, Jing Dai, Jiazheng Cai, Masahito Fujio, Yiwen Xu, Xiaoli An, Ying Xue

PMC · DOI: 10.3390/pharmaceutics17050643 · Pharmaceutics · 2025-05-13

## TL;DR

This paper introduces a new membrane that combines a biological matrix with Resolvin D1 to control inflammation and promote bone regeneration.

## Contribution

The novel integration of Resolvin D1 into a biocompatible membrane for inflammation control and tissue regeneration is presented.

## Key findings

- BRL membrane showed a three-dimensional pore structure and slow release of RvD1.
- BRL improved MG63 cell viability and reduced LPS-induced inflammation.
- Osteogenesis-related genes were significantly upregulated by BRL.

## Abstract

Background/Objectives: Constant inflammation can be a detrimental response in bone regeneration. To regulate of the inflammatory response and synchronically promote rapid tissue regeneration is a vital clinical challenge. The urinary bladder matrix (UBM) and small intestinal submucosa (SIS) composite are commonly used extracellular matrix (ECM) materials. We designed a novel drug-loaded membrane by integrating the biological matrix (BM) composed of UBM and SIS composites with Resolvin D1 (RvD1), an endogenous pro-resolving lipid mediator, using the lyophilization process. This membrane is referred to as BRL, an acronym for BM-RvD1-Lyophilization. Methods: In this study, the physicochemical properties of the membranes were characterized. Fluorescence staining and the CCK8 assay kit were utilized to assess biocompatibility. To evaluate the inflammatory resolution properties and osteogenic ability of osteoblasts, real-time quantitative PCR and ELISA were conducted. Results: BRL exhibited a more pronounced three-dimensional pore structure, demonstrating excellent physicochemical properties and enabling the slow release of RvD1. This approach improved the viability of MG63 osteoblast-like cells, reduced LPS-induced inflammation, and upregulated osteogenesis-related genes significantly. Conclusions: By integrating inflammation control capabilities into tissue regeneration materials, BRL effectively regulates the tissue regeneration microenvironment, thereby enhancing regeneration efficiency and positioning itself as an exceptional candidate for future tissue regeneration membranes.

## Linked entities

- **Chemicals:** Resolvin D1 (PubChem CID 44251266)

## Full-text entities

- **Genes:** BRD1 (bromodomain containing 1) [NCBI Gene 23774] {aka BRL, BRPF2}
- **Diseases:** Inflammation (MESH:D007249)
- **Chemicals:** Resolvin D1 (MESH:C518399), LPS (MESH:D008070), lipid (MESH:D008055), CCK8 (MESH:D012844)
- **Cell lines:** MG63 — Homo sapiens (Human), Osteosarcoma, Cancer cell line (CVCL_0426)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12114963/full.md

## Figures

7 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12114963/full.md

## References

48 references — full list in the complete paper: https://tomesphere.com/paper/PMC12114963/full.md

---
Source: https://tomesphere.com/paper/PMC12114963